TMDX (TransMedics Organ Care System) Company Projected Revenue
TransMedics Group (TMDX) possesses exceptional pricing power thanks to its vital OCS system. The company's monopoly status is confirmed by the willingness of clinics to cover any costs to save patients. Revenues are based on the sale of perfusion systems and organ logistics. The company's expected sales volume on this chart demonstrates market prospects, and 0.43 determines the latest valuation metric.
Analytical breakdowns and data insights for company TransMedics Group Inc (TMDX)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital TransMedics Group|TMDX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital TransMedics Corp|TMDX - Company Total Debt|Debts to Book Capitalization TransMedics Group Inc|TMDX - Company Long-Term Debts|Company Short-Term Debt TransMedics|Quick Liquidity Indicator transmedics.com
- earnings and market ratios statistics:
TMDX - Final Profit|Projected Future Earnings TransMedics Group|TMDX - Market Cap to Earnings|Future Price to Earnings transmedics.com|TMDX - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio TransMedics Group Inc|TMDX - Operating profit EBITDA|Net earnings per share (EPS TTM) TransMedics|TMDX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months transmedics.com|TMDX - Earnings per share trend in current year|Net earnings per share growth forecast for next year TransMedics Group
- sales and revenue data:
Fundamental company analysis:TransMedics Group
The innovative approach of TransMedics Group (TMDX) management to transforming organ logistics directly determines the dynamics of the company's projected revenue. This indicator aggregates simulated market proceeds, allowing investors to assess the fundamental value of the business and identify risk asymmetry through an analysis of the capital recovery rate, where each value may signal either upcoming growth or a deepening correction.
Analysis of competing companies
Company Future Sales Volume BSX (Boston Scientific)|EW (edwards.com) - Company Future Revenue|Company Projected Revenue ResMed RMD|PODD - Company Future Sales Volume|Zimmer - Projected Sales Volume|Company Expected Sales Volume CooperSurgical|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|ATEC (Alphatec) - Projected Sales Volume|CryoLife (AORT) - Company Future Sales|Projected Sales Volume ENOV|Company Future Sales Volume Integra LifeSciences Inc. IART|Projected Sales Volume ESTA (Establishment Labs)|Projected Sales Volume betabionics.com BBNX|IRMD - Company Projected Revenue|EMBC: Company Projected Revenue|TNDM (Tandem Diabetes) - Company Future Sales Volume|Axogen Surgical - Company Future Revenue|SIBN (SI-BONE, Inc.) - Projected Sales Volume|Company Expected Sales Volume orthofix.com OFIX|Company Projected Revenue Bioventus (BVS)|orthopediatrics.com (KIDS) - Company Sales Forecast|Treace Medical - Company Future Sales Volume|Projected Sales Volume Strata Medical SRTA|Carlsmed Inc - Projected Sales Volume|Company Future Sales rxsight.com RXST|clearpointneuro.com (CLPT) - Company Projected Revenue|Company Expected Revenue STXS (Stereotaxis Inc)|Company Projected Revenue NeuroStar|Company Future Sales Volume Sight Sciences Inc (SGHT)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings - Company Projected Revenue Volume|NMTC (NeuroOne Medical Technologies) - Company Future Sales Volume|MODD: Company Projected Revenue Volume|Company Projected Revenue Myomo|COCH: Company Future Revenue|Projected Sales Volume VVOS|Projected Sales Volume enVVeno Corp (NVNO)|Company Projected Revenue Sintx Technologies, Inc. SINT|TNON: Company Revenue Forecast|LFWD - Company Projected Revenue|Company Future Sales Autonomix Medical, Inc. AMIX|INVO Bioscience, Inc. (IVF) - Company Projected Revenue|Company Future Sales Volume Bone Biologics Inc|AXNX (Axonics, Inc.) - Projected Sales Volume|Company Expected Sales Volume biolase.com BIOL|Projected Sales Volume DYNT|paragon28.com - Company Revenue Forecast|Projected Sales Volume INVO (INVO Bioscience)
